Prostate Cancer Screening in Kuala Lumpur
PSA testing and individual risk assessment, with further tests considered when appropriate.
Prostate cancer screening aims to identify men who may be at increased risk before symptoms develop. PSA testing is usually the starting point, while further assessment such as PHI, prostate MRI or biopsy may be considered depending on the PSA result and individual risk.
Overview
Prostate cancer can develop without causing symptoms, particularly in its early stages. Screening aims to identify men who may be at increased risk before symptoms appear.
The main screening test is a blood test called prostate-specific antigen (PSA). PSA is not a cancer test by itself: an elevated result can occur for several reasons, and some prostate cancers may occur despite a PSA that is not markedly raised.
Screening should therefore be an informed, individual decision. Age, family history, overall health and personal preferences are considered when deciding whether PSA testing is appropriate and what to do with the result.
From Screening to Further Assessment
| Step | Purpose |
|---|---|
| PSA blood test | Main blood test used in prostate cancer screening |
| Clinical risk assessment | Considers age, family history, health and other risk factors |
| PHI or prostate MRI | May help assess risk further when PSA or other findings are concerning |
| Prostate biopsy | Used when needed to confirm whether prostate cancer is present |
Who Should Consider Prostate Cancer Screening?
The decision to have PSA testing should be individualised. A discussion about prostate cancer screening may be appropriate for men who:
- Are in an age group where prostate cancer screening may offer benefit
- Have a father or brother with prostate cancer, particularly if diagnosed at a younger age
- Have a strong family history of prostate cancer or certain related cancers
- Have known inherited risk factors associated with prostate cancer
- Would like to understand the potential benefits and limitations of PSA screening before deciding whether to be tested
Men at increased risk may benefit from discussing screening at a younger age than men at average risk. The appropriate age to start and how often PSA should be checked depend on individual risk, previous PSA results, overall health and personal preferences.
Screening Is Different From Investigating Symptoms
Prostate cancer screening generally refers to testing men who do not have symptoms suggestive of prostate cancer.
Men who already have a raised PSA, an abnormal prostate examination, blood in the urine, or other concerning findings may require diagnostic assessment rather than routine screening.
Similarly, urinary symptoms such as a weak stream, frequent urination or waking at night to urinate are commonly caused by benign prostate conditions and do not necessarily indicate prostate cancer.
Already have a raised PSA? Read how a raised PSA is assessed and when MRI or biopsy may be considered. →
What Does Prostate Cancer Screening Involve?
PSA blood testing is the main test used for prostate cancer screening. If the result or overall risk raises concern, further assessment may then include additional blood tests, clinical examination, prostate MRI or biopsy.
PSA Blood Test
PSA, or prostate-specific antigen, is a protein produced by the prostate.
A raised PSA level can be associated with prostate cancer, but it can also occur due to non-cancer causes such as benign prostate enlargement, inflammation, infection, recent ejaculation, catheterisation, or recent prostate procedures.
This is why PSA should not be interpreted on its own. The PSA level, PSA trend, age, prostate size, symptoms, and family history all need to be considered together.
Read more about how a raised PSA is assessed.
Further Blood Testing: Prostate Health Index (PHI)
In some men with a raised or borderline PSA, a Prostate Health Index, or PHI, may be considered.
PHI is a blood test that combines different PSA measurements into a single score. It may help refine the risk of prostate cancer and support decision-making about whether further tests, such as prostate MRI or biopsy, are needed.
PHI does not diagnose prostate cancer by itself. It is interpreted together with the PSA level, PSA trend, age, prostate size, family history, examination findings, and MRI results where available.
A higher PHI score may suggest a higher likelihood of finding prostate cancer on biopsy, while a lower score may support a more cautious approach in selected cases.
Read more about PHI testing.
Clinical Assessment
A urologist will usually review your age, symptoms, medical background, family history, medications, previous PSA results, and any previous prostate imaging or biopsy results.
In some cases, a prostate examination may be recommended as part of the overall assessment.
Prostate MRI
If the PSA, PHI, examination findings, or overall risk assessment raises concern, a multiparametric prostate MRI may be recommended.
MRI can help identify suspicious areas within the prostate. It may also help guide whether a biopsy is needed and which area should be sampled.
MRI is not normally used as the initial screening test for prostate cancer and does not replace PSA-based risk assessment.
Read more about MRI prostate.
Prostate Biopsy
A prostate biopsy is considered when there is sufficient concern based on PSA, PHI, MRI findings, examination findings, or overall risk.
A biopsy involves taking small samples of prostate tissue for laboratory analysis. It is the test that confirms whether prostate cancer is present.
Not every raised PSA requires an immediate biopsy. Depending on the circumstances, repeat PSA testing, additional risk assessment, PHI testing or prostate MRI may be considered before deciding whether biopsy is appropriate. If a urinary or prostate infection is clinically suspected, this is assessed and treated accordingly.
Read more about transperineal prostate biopsy.
A Raised PSA Does Not Always Mean Cancer
PSA is prostate-specific, but it is not cancer-specific. A raised result can occur with benign prostate enlargement, inflammation, infection and several other non-cancerous conditions.
A raised PSA therefore needs to be interpreted in context rather than used alone to diagnose prostate cancer.
If your PSA is already raised, read: Raised PSA — Do I Need a Prostate Biopsy?
What Happens if the Screening Result Is Abnormal?
An abnormal screening result does not mean that prostate cancer is present. It means that further assessment may be appropriate.
Depending on the PSA result and individual risk, the next step may include repeating the PSA, reviewing prostate size and PSA density, considering additional biomarkers such as PHI, performing a prostate MRI, or discussing prostate biopsy.
The aim is to identify men who are more likely to benefit from further investigation while avoiding unnecessary procedures where possible.
Benefits and Limitations of Prostate Cancer Screening
PSA screening can help identify prostate cancer at an earlier stage, including cancers that may be more effectively treated when detected before they have spread.
Screening also has limitations. PSA is not specific for cancer, so an abnormal result may lead to additional testing even when cancer is not present. Screening can also identify slow-growing prostate cancers that may never have caused harm during a man’s lifetime.
For this reason, the decision to undergo PSA screening should involve discussion of both potential benefits and possible harms, including false-positive results, further investigations, biopsy, overdiagnosis and the possibility of active surveillance rather than immediate treatment.
Prostate Cancer Risk Assessment in Kuala Lumpur
A prostate cancer risk assessment may involve reviewing PSA results, PHI results where appropriate, urinary symptoms, family history, prostate size, MRI findings, and previous biopsy results if available.
The purpose is to place an individual PSA result in context and determine whether monitoring or further investigation is appropriate. Not every man requires the same tests, and not every abnormal PSA result requires biopsy.
At Prince Court Medical Centre, men can discuss PSA results and prostate cancer risk with Dr Roger Anthony Idi, Consultant Urologist, including whether monitoring or further investigation may be appropriate.
When Should You See a Urologist?
A urology assessment may be helpful if you have:
- A raised or persistently abnormal PSA
- A PSA result that is difficult to interpret
- A concerning PHI or prostate MRI result
- An abnormal prostate examination
- A strong family history or other increased prostate cancer risk
- A previous negative biopsy but ongoing clinical concern
- Questions about whether further investigation or biopsy is appropriate
A referral does not necessarily mean that prostate cancer is suspected or that a biopsy will be required. The purpose is to assess the findings in context and decide on the most appropriate next step.
Considering Prostate Cancer Screening?
The decision to undergo PSA screening should take into account age, individual risk, overall health and personal preferences. If a PSA test has already been performed, a urology assessment can help interpret the result and determine whether any further investigation is appropriate.
Appointments with Dr Roger Anthony Idi are arranged through Prince Court Medical Centre.
FAQ
What is prostate cancer screening?
Prostate cancer screening aims to identify men who may be at increased risk of prostate cancer before symptoms develop. PSA blood testing is the main screening test, with further assessment considered if the result or individual risk raises concern.
At what age should men consider PSA screening?
For men at average risk, discussion about PSA screening commonly begins from around age 50. Men at increased risk, such as those with a strong family history of prostate cancer, may benefit from discussing screening earlier. The appropriate starting age should be individualised.
Do all men need prostate cancer screening?
No. The decision to undergo screening should be individualised after considering the potential benefits and limitations of PSA testing, personal risk factors and preferences.
Who may need to consider screening earlier?
Men with a father or brother who developed prostate cancer, particularly at a younger age, and men with a strong family history or known inherited risk factors may benefit from discussing screening earlier.
Can prostate cancer occur without symptoms?
Yes. Early prostate cancer often causes no symptoms. This is one reason PSA screening may be considered in men of an appropriate age or those at increased risk.
Does a high PSA always mean prostate cancer?
No. PSA can also be raised by benign prostate enlargement, inflammation, infection and other non-cancerous conditions. A raised result needs to be interpreted together with other clinical information.
What happens if my PSA is raised?
A raised PSA does not automatically mean cancer. Depending on the result and individual risk, further assessment may include repeat PSA testing, additional risk assessment, PHI testing, prostate MRI or consideration of biopsy.
Does an abnormal PSA mean I need a biopsy?
Not necessarily. The decision to perform a biopsy depends on the PSA result, PSA trend, prostate size, examination findings, MRI findings and other individual risk factors.